Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Chemicals Industry Analysis

UpdatedSep 21, 2026
DataAggregated Company Financials
Companies5
  • 7D1.3%
  • 3M8.7%
  • 1Y9.3%
  • YTD16.3%

Over the last 7 days, the Chemicals industry has risen 1.3%, driven by gains in Givaudan and EMS-CHEMIE HOLDING of 1.3% and 1.9%, respectively. This takes the industry's 12 month performance to a gain of 9.3%. Looking forward, earnings are forecast to grow by 10% annually.

Industry Valuation and Performance

Has the Swiss Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 21 Sep 2026CHF 81.7bCHF 24.6bCHF 2.5b29.8x33.3x3.3x
Wed, 19 Aug 2026CHF 80.8bCHF 24.6bCHF 2.4b30.6x34.1x3.3x
Fri, 17 Jul 2026CHF 77.5bCHF 24.9bCHF 2.4b29.3x31.7x3.1x
Sun, 14 Jun 2026CHF 73.2bCHF 24.9bCHF 2.4b27.4x29.9x2.9x
Tue, 12 May 2026CHF 66.7bCHF 24.9bCHF 2.4b23.7x27.3x2.7x
Thu, 09 Apr 2026CHF 65.7bCHF 24.9bCHF 2.4b24.1x26.8x2.6x
Sat, 07 Mar 2026CHF 66.3bCHF 24.9bCHF 2.4b24.8x27.1x2.7x
Mon, 02 Feb 2026CHF 67.9bCHF 25.4bCHF 2.7b23.3x24.7x2.7x
Wed, 31 Dec 2025CHF 70.4bCHF 25.4bCHF 2.8b24.2x25.4x2.8x
Fri, 28 Nov 2025CHF 71.3bCHF 25.4bCHF 2.8b24.5x25.8x2.8x
Sun, 26 Oct 2025CHF 76.7bCHF 25.4bCHF 2.8b26.3x27.7x3x
Tue, 23 Sep 2025CHF 74.7bCHF 25.6bCHF 2.8b25.5x26.7x2.9x
Thu, 21 Aug 2025CHF 79.9bCHF 25.7bCHF 2.9b27.1x27.9x3.1x
Sat, 19 Jul 2025CHF 85.2bCHF 25.8bCHF 3.0b29.1x28.3x3.3x
Mon, 16 Jun 2025CHF 88.4bCHF 25.8bCHF 3.0b28.6x29.3x3.4x
Wed, 14 May 2025CHF 89.0bCHF 25.8bCHF 3.0b29.5x29.5x3.4x
Fri, 11 Apr 2025CHF 80.5bCHF 25.8bCHF 3.0b26.6x26.7x3.1x
Sun, 09 Mar 2025CHF 93.8bCHF 25.8bCHF 3.0b32x31.1x3.6x
Tue, 04 Feb 2025CHF 92.8bCHF 25.8bCHF 2.9b32.3x31.8x3.6x
Thu, 02 Jan 2025CHF 88.9bCHF 25.5bCHF 2.9b31x31.1x3.5x
Sat, 30 Nov 2024CHF 90.6bCHF 25.5bCHF 2.9b31.7x31.7x3.5x
Mon, 28 Oct 2024CHF 98.5bCHF 25.5bCHF 2.9b35x34.4x3.9x
Wed, 25 Sep 2024CHF 105.3bCHF 25.6bCHF 2.8b34.1x37x4.1x
Fri, 23 Aug 2024CHF 102.2bCHF 25.7bCHF 2.8b36.3x36x4x
Sun, 21 Jul 2024CHF 103.1bCHF 25.2bCHF 2.6b37x39.8x4.1x
Tue, 18 Jun 2024CHF 102.3bCHF 25.2bCHF 2.6b37.2x39.5x4.1x
Thu, 16 May 2024CHF 106.4bCHF 25.2bCHF 2.6b39.4x41.1x4.2x
Sat, 13 Apr 2024CHF 99.4bCHF 25.2bCHF 2.5b38.3x40x3.9x
Mon, 11 Mar 2024CHF 97.0bCHF 25.2bCHF 2.5b39.9x38.2x3.9x
Wed, 07 Feb 2024CHF 90.7bCHF 25.7bCHF 2.2b37.3x41.1x3.5x
Fri, 05 Jan 2024CHF 95.4bCHF 26.1bCHF 2.3b35.6x42.2x3.7x
Sun, 03 Dec 2023CHF 90.6bCHF 26.1bCHF 2.3b34.8x40x3.5x
Tue, 31 Oct 2023CHF 83.4bCHF 26.1bCHF 2.3b31.3x36.8x3.2x
Thu, 28 Sep 2023CHF 84.8bCHF 25.7bCHF 2.2b32.2x38.1x3.3x
Price to Earnings Ratio

38.1x


Total Market Cap: CHF 84.8bTotal Earnings: CHF 2.2bTotal Revenue: CHF 25.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Chemicals Industry Price to Earnings3Y Average 32.8x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swiss Chemicals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 32.8x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Chemicals industry have grown 3.3% per year over the last three years, while revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Industry Trends

Which industries have driven the changes within the Swiss Materials industry?

CH Market-0.19%
Materials-0.20%
Chemicals1.30%
Specialty Chemicals1.30%
Industry PE
  • Investors are most optimistic about the Specialty Chemicals industry, which is trading close to its 3-year average PE ratio of 32.8x.
    • Analysts are expecting annual earnings growth of 10.4%, which is higher than its past year's earnings decline of 12.8% per year.
  • Investors are most pessimistic about the Specialty Chemicals industry, which is trading close to its 3-year average of 32.8x.
Forecasted Growth
  • Analysts are most optimistic on the Specialty Chemicals industry, expecting annual earnings growth of 10% over the next 5 years.
  • This is better than its past earnings decline of 13% per year.
  • In contrast, the Specialty Chemicals industry is expected to see its earnings grow by 10% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GIVN GivaudanCHF 3.37k5.1%
+CHF 1.5b		3.0%PE32.6x
SIKA SikaCHF 185.502.6%
+CHF 746.0m		4.3%PE28.6x
EMSN EMS-CHEMIE HOLDINGCHF 812.503.6%
+CHF 666.6m		41.2%PE40.1x
CLN ClariantCHF 10.572.2%
+CHF 75.6m		42.5%PS0.9x
GURN Gurit HoldingCHF 57.603.2%
+CHF 8.4m		350.0%PE15.9x

Latest News

EMSN
CHF 812.50
EMS-CHEMIE HOLDING
7D
3.6%
1Y
41.2%
GURN
CHF 57.60
Gurit Holding
7D
3.2%
1Y
350.0%
Narrative Update • Sep 09

GURN: Raised 2026 Sales Guidance Will Support Stronger Earnings Profile

Analysts have raised their price target for Gurit Holding from CHF 43 to CHF 75, citing updated assumptions for higher revenue growth, a slightly stronger profit margin profile, and a higher future P/E multiple. What’s in the News for Gurit Holding Gurit Holding raised its sales guidance for 2026, now expecting net sales growth for continuing operations at constant exchange rates in a range of 9% to 11%, compared with prior guidance that pointed to mid single digit growth.
GIVN
CHF 3,370.00
Givaudan
7D
5.1%
1Y
3.0%
Narrative Update • Sep 09

GIVN: Broader Execution And Lower Oil Costs Will Support Future Re Rating

Givaudan's analyst-derived fair value estimate has been trimmed from CHF 4,283.53 to CHF 4,010.60 as analysts balance a wider range of price targets, with some citing pressure on Fine Fragrance premiumization and mixed ratings across the stock. Analyst Commentary Recent research on Givaudan shows a split set of views, but there are several points that more optimistic analysts continue to highlight.
SIKA
CHF 185.50
Sika
7D
2.6%
1Y
4.3%
CLN
CHF 10.57
Clariant
7D
2.2%
1Y
42.5%
Narrative Update • Sep 03

CLN: Litigation Outcomes And Earnings Outlook Will Shape Measured Forward Expectations

Clariant's analyst price target has been raised from CHF 8.58 to CHF 10.41 as analysts factor in higher forecast revenue growth, slightly stronger profit margins and reduced litigation risk, reflected in a series of recent target upgrades into the CHF 10 to CHF 13 range. Analyst Commentary Recent Street research on Clariant has shifted toward a more positive stance, with several large banks and other bullish analysts lifting ratings and targets into a CHF 10 to CHF 13 band.